SERUM MICRORNA 362-3P AS A POTENTIAL BIOMARKER TO PREDICT THE EXTENT OF DRUG-INDUCED QT INTERVAL LENGTHENING AMONG HEART FAILURE PATIENTS
| dc.contributor.advisor | Dr. Brian R. Overholser | |
| dc.contributor.author | RAKAN JAMAL ALANAZI | |
| dc.date | 2020 | |
| dc.date.accessioned | 2022-06-02T09:54:30Z | |
| dc.date.available | 2022-06-02T09:54:30Z | |
| dc.degree.department | Pharmacy Practice | |
| dc.degree.grantor | Purdue University | |
| dc.description.abstract | SERUM MICRORNA 362-3P AS A POTENTIAL BIOMARKER TO PREDICT THE EXTENT OF DRUG-INDUCED QT INTERVAL LENGTHENING AMONG HEART FAILURE PATIENTS | |
| dc.identifier.uri | https://drepo.sdl.edu.sa/handle/20.500.14154/62779 | |
| dc.language.iso | en | |
| dc.title | SERUM MICRORNA 362-3P AS A POTENTIAL BIOMARKER TO PREDICT THE EXTENT OF DRUG-INDUCED QT INTERVAL LENGTHENING AMONG HEART FAILURE PATIENTS | |
| sdl.thesis.level | Master | |
| sdl.thesis.source | SACM - United States of America |